Labcyte Launches New Family of Echo® Acoustic Liquid Handlers featuring 21 CFR Part 11 Compliance Software
State-of-the-art software supports laboratories working in regulated environments
February 05, 2018
SAN DIEGO and SAN JOSE, CA
Labcyte Inc. today announced the release of a regulatory-ready family of Echo® Acoustic Liquid Handlers intended for pharmaceutical companies and laboratories developing and running bioassays. Integral to this new capability of Echo liquid handlers is new software, Echo® 21CFR11 Compliance Manager, and services designed to simplify deployment in regulated laboratories that must comply with the 21 CFR Part 11 regulations established by the U.S. Food and Drug Administration. Regulatory-ready versions of the Echo® 525, 550, and 555 Acoustic Liquid handlers are among several other new products the company introduced today at SLAS2018 in San Diego.
Echo® 21CFR11 Compliance Manager, software included with the regulatory-ready systems, seamlessly integrates with Echo liquid handlers and Echo® software applications to control who can view, create, edit, approve, archive, and delete data that is generated by the systems. Using advanced proprietary verification algorithms, the software also detects any data tampering to give users confidence in the integrity of their data.
"The new regulatory-ready Echo® Liquid Handlers make it easier for laboratories to successfully install, qualify and operate the system in a regulated laboratory environment," said Chris Grimley, Vice President of Marketing for Labcyte. "Echo 21CFR11 Compliance Manager software prevents unwanted changes to system settings or protocols and maintains full traceability of system use, which is critical for bioassay development and implementation."
Acoustic liquid handling, pioneered by Labcyte, has been adopted across pharmaceutical sample management and screening programs for the dispensing of reagents in a wide variety of molecular and cellular assays. It uses the gentle energy of sound waves to move liquids in nanoliter increments with extremely high precision and accuracy. The technology is contactless, avoiding risks of sample carryover or cross-contamination and reduces sample volume needs, which in turn leads to improved data quality, higher throughput, and lower assay costs.
For more information about the Echo 21CFR11 Compliance Manager, visit: www.labcyte.com/products/software/echo-compliance-manager. For more information about Labcyte activities at SLAS2018, including a series of tutorial workshops, visit www.labcyte.com/slas2018/. Attendees can also visit representatives of the company at booth 915-921.
About Labcyte Inc.
Labcyte, a global biotechnology tools company headquartered in San Jose, California, is revolutionizing liquid handling. Echo® Liquid Handlers use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical and biotechnology industries, as well as by hospitals, service laboratories, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics, and personalized medicine. Labcyte has 62 U.S. patents and others internationally. For more information, visit www.labcyte.com.
- PR Contact:
- Nicole Litchfield
- Bioscribe, Inc.